Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus.
- Published In:
- Emerging microbes & infections, 10(1), 810-821 (2021)
- Authors:
- Zhu, Yun, Yu, Danwei, Yan, Hongliang, Chong, Huihui, He, Yuxian
- Database ID:
- RPEP-05941
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05941APA
Zhu, Yun; Yu, Danwei; Yan, Hongliang; Chong, Huihui; He, Yuxian. (2021). Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus.. Emerging microbes & infections, 10(1), 810-821. https://doi.org/10.1080/22221751.2021.1917309
MLA
Zhu, Yun, et al. "Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus.." Emerging microbes & infections, 2021. https://doi.org/10.1080/22221751.2021.1917309
RethinkPeptides
RethinkPeptides Research Database. "Pan-coronavirus fusion inhibitors possess potent inhibitory ..." RPEP-05941. Retrieved from https://rethinkpeptides.com/research/zhu-2021-pancoronavirus-fusion-inhibitors-possess-potent
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.